Why RNTX? Rein Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
RNTX
$1.03-0.33 (-23.99%)
Market ClosedLast close May 1
Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States.